| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 25 |
| 1 | METHOTREXATE | 24 |
| 2 | DURVALUMAB | 20 |
| 3 | ASPIRIN | 18 |
| 4 | ASPIRIN 325 MG | 18 |
| 5 | ASPIRIN 81 MG | 18 |
| 6 | NIVOLUMAB | 17 |
| 7 | PREDNISONE | 17 |
| 8 | ALENDRONATE SODIUM | 16 |
| 9 | OMEPRAZOLE MAGNESIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOLMETIN SODIUM | 1 | 0.0059 |
| 1 | NICARDIPINE HYDROCHLORIDE | 4 | 0.0018 |
| 2 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| 3 | HYDROQUINONE | 1 | 0.0017 |
| 4 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 5 | PILOCARPINE HYDROCHLORIDE | 3 | 0.0012 |
| 6 | NICARDIPINE | 5 | 0.0011 |
| 7 | AVELUMAB | 4 | 0.0010 |
| 8 | DURVALUMAB | 20 | 0.0009 |
| 9 | TRIAZOLAM | 3 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 20 | 0.0009 |
| 1 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 2 | Gadolinium-based Contrast Agent [EPC] | 2 | 0.0004 |
| 3 | Progesterone [EPC] | 8 | 0.0003 |
| 4 | Alkaloid [EPC] | 7 | 0.0003 |
| 5 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 8 | 0.0002 |
| 6 | Rifamycin Antibacterial [EPC] | 9 | 0.0002 |
| 7 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 10 | 0.0002 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 | 0.0002 |